Results 71 to 80 of about 6,281,072 (400)

Medical Book Publishing [PDF]

open access: yes, 1958
published or submitted for ...
Johnson, Barbara Coe
core  

Authors and open access publishing [PDF]

open access: yes, 2004
Surveys were carried out to learn more about authors and open access publishing. Awareness of open access journals among those who had not published in them was quite high; awareness of "self-archiving" wasless.
Brown, Sheridan, Swan, Alma
core   +1 more source

The dual nature of TDC – bridging dendritic and T cells in immunity

open access: yesFEBS Letters, EarlyView.
TDC are hematopoietic cells combining dendritic and T cell features. They reach secondary lymphoid organs (SLOs) and peripheral organs (liver and lungs) after FLT3‐dependent development in the bone marrow and maturation in the thymus. TDC are activated and enriched in SLOs upon viral infection, suggesting that they might play unique immune roles, since
Maria Nelli, Mirela Kuka
wiley   +1 more source

Genome Integrity: A new open access journal [PDF]

open access: yes, 2010
The full and final version of this article can be found at the link belowThis article has been made available through the Brunel Open Access Publishing Fund.This article is available through the Brunel Open Access Publishing ...
Hakem, R   +3 more
core   +2 more sources

Leveraging current insights on IL‐10‐producing dendritic cells for developing effective immunotherapeutic approaches

open access: yesFEBS Letters, EarlyView.
In vivo IL‐10 produced by tissue‐resident tolDC is involved in maintaining/inducing tolerance. Depending on the agent used for ex vivo tolDC generation, cells acquire common features but prime T cells towards anergy, FOXP3+ Tregs, or Tr1 cells according to the levels of IL‐10 produced. Ex vivo‐induced tolDC were administered to patients to re‐establish/
Konstantina Morali   +3 more
wiley   +1 more source

FoxO1 signaling in B cell malignancies and its therapeutic targeting

open access: yesFEBS Letters, EarlyView.
FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac   +3 more
wiley   +1 more source

At last : intelligent publishing! [PDF]

open access: yes, 2012
Scientific publishing was simpler when we only had paper to use. In the Earth sciences, for example, we had printed maps, books, reports, pamphlets and journal papers, all very familiar to publishers and readers.
Westhead, Keith
core  

Decentralized provenance-aware publishing with nanopublications [PDF]

open access: yes, 2016
Publication and archival of scientific results is still commonly considered the responsability of classical publishing companies. Classical forms of publishing, however, which center around printed narrative articles, no longer seem well-suited in the ...
Chichester, Christine   +8 more
core   +4 more sources

Publisher's Comment

open access: yesJournal of Biocommunication, 2016
This Publisher's Comment provides an overview of the content for issue 43-1 of the Journal of Biocommunication. This publication represents our first issue of 2019, and it is our sixth issue designed for our new mixed publishing format.Journal Management Board for the ...
openaire   +17 more sources

Making tau amyloid models in vitro: a crucial and underestimated challenge

open access: yesFEBS Letters, EarlyView.
This review highlights the challenges of producing in vitro amyloid assemblies of the tau protein. We review how accurately the existing protocols mimic tau deposits found in the brain of patients affected with tauopathies. We discuss the important properties that should be considered when forming amyloids and the benchmarks that should be used to ...
Julien Broc, Clara Piersson, Yann Fichou
wiley   +1 more source

Home - About - Disclaimer - Privacy